NASDAQ: UTMD
Utah Medical Products Inc Stock

$67.84-1.60 (-2.3%)
Updated Jun 12, 2026
UTMD Price
$67.84
Fair Value Price
$92.43
Market Cap
$216.00M
52 Week Low
$52.00
52 Week High
$71.81
P/E
20.07x
P/B
1.79x
P/S
5.26x
PEG
9.5x
Dividend Yield
1.81%
Revenue
$37.53M
Earnings
$10.85M
Gross Margin
57.9%
Operating Margin
35.79%
Profit Margin
28.9%
Debt to Equity
0.03
Operating Cash Flow
$13M
Beta
0.52
Next Earnings
N/A
Ex-Dividend
Jun 17, 2026
Next Dividend
Jul 3, 2026

UTMD Overview

Utah Medical Products, Inc. (UTMD) is a healthcare technology company focused on the creation, production, and supply of medical devices for the healthcare sector. UTMD offers a comprehensive portfolio of medical devices primarily serving labor and delivery departments and neonatal intensive care units. Key offerings include fetal monitoring accessories, vacuum-assisted delivery systems, and other specialized tools for childbirth. For newborns, they provide respiratory hoods (DISPOSA-HOOD), umbilical vessel catheters (GESCO), silicone oral protection devices (PALA-NATE), and lumbar sampling kits (MYELO-NATE). Beyond maternity care, the company supplies blood pressure monitoring systems (DELTRAN PLUS), disposable peritoneal dialysis sets (DIALY-NATE), urinary drainage systems (URI-CATH), and feeding devices (NUTRI-CATH/NUTRI-LOK). They also manufacture HEMO-NATE disposable filters, various catheterization procedure trays, and DELTRAN disposable pressure transducers along with related accessories and molded parts. A substantial portion of UTMD's offerings targets women's health and gynecological interventions. This includes advanced electrosurgical solutions like the LETZ system for cervical lesion excision, paired with FINESSE+ generators and various specialized electrodes (loop, ball, needle), and FILTRESSE evacuators. They also provide laparoscopic instruments (Femcare line), including trocars and cannulae, alongside EPITOME and OptiMicro electrosurgical devices. Complementing these are products for surgical contraception (Filshie Clip), endoscopic irrigation (PATHFINDER PLUS), suprapubic catheterization, and urinary incontinence management (LIBERTY systems). Specialized tools for uterine assessment and sampling, such as the ENDOCURETTE and TVUS/HSG-Cath, as well as the LUMIN uterine manipulator for laparoscopic procedures, complete this extensive portfolio. UTMD's diverse product range serves various healthcare settings, including neonatal intensive care units, labor and delivery wards, women's health centers within hospitals, outpatient clinics, and physicians' offices. The company facilitates distribution through a combination of direct customer service and sales teams, independent consultants, and manufacturer representatives. Established in 1978, Utah Medical Products, Inc. maintains its headquarters in Midvale, Utah.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine UTMD's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical

Industry Rating
B
UTMD
Ranked
#25 of 42

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$9.14A
$142.20B
$15.08B
View Top Medical Stocks

Be the first to know about important UTMD news, forecast changes, insider trades & much more!

Overview

Due Diligence Score

Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how UTMD scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

UTMD ($67.84) is undervalued by 26.6% relative to our estimate of its Fair Value price of $92.43 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
UTMD ($67.84) is significantly undervalued by 26.6% relative to our estimate of its Fair Value price of $92.43 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
UTMD ($67.84) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more UTMD due diligence checks available for Premium users.

Valuation

UTMD fair value

Fair Value of UTMD stock based on Discounted Cash Flow (DCF)

Price
$67.84
Fair Value
$92.43
Undervalued by
26.60%
UTMD ($67.84) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
UTMD ($67.84) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
UTMD ($67.84) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

UTMD price to earnings (PE)

For valuing profitable companies with steady earnings

Company
20.07x
Industry
42.82x
Market
14.15x
UTMD is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
UTMD is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

UTMD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
1.79x
Industry
3.19x
UTMD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

UTMD price to earnings growth (PEG)

For valuing profitable companies with growth potential

UTMD is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

UTMD's financial health

Profit margin

Revenue
$8.7M
Net Income
$2.6M
Profit Margin
29.9%
UTMD's Earnings (EBIT) of $13.43M... subscribe to Premium to read more.
Interest Coverage Financials
UTMD's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$124.4M
Liabilities
$4.0M
Debt to equity
0.03
UTMD's short-term assets ($100.38M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
UTMD's short-term assets ($100.38M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
UTMD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
UTMD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$3.1M
Investing
-$130.0k
Financing
-$1.1M
UTMD's operating cash flow ($13.34M)... subscribe to Premium to read more.
Debt Coverage Financials

UTMD vs Medical Stocks

TickerZen RatingMarket Cap1d %P/EP/B
UTMDC$216.00M-2.30%20.07x1.79x
PDEXB$198.59M-1.14%16.81x4.39x
SMTIB$190.70M-3.21%-5.36x27.13x
INFUA$184.46M+0.99%24.05x3.14x
EMBCC$183.92M+0.65%1.61x-0.29x

Utah Medical Products Stock FAQ

What is Utah Medical Products's quote symbol?

(NASDAQ: UTMD) Utah Medical Products trades on the NASDAQ under the ticker symbol UTMD. Utah Medical Products stock quotes can also be displayed as NASDAQ: UTMD.

If you're new to stock investing, here's how to buy Utah Medical Products stock.

What is the 52 week high and low for Utah Medical Products (NASDAQ: UTMD)?

(NASDAQ: UTMD) Utah Medical Products's 52-week high was $71.81, and its 52-week low was $52.00. It is currently -5.52% from its 52-week high and 30.46% from its 52-week low.

How much is Utah Medical Products stock worth today?

(NASDAQ: UTMD) Utah Medical Products currently has 3,184,025 outstanding shares. With Utah Medical Products stock trading at $67.84 per share, the total value of Utah Medical Products stock (market capitalization) is $216.00M.

Utah Medical Products stock was originally listed at a price of $6.00 in Mar 8, 1999. If you had invested in Utah Medical Products stock at $6.00, your return over the last 27 years would have been 1,030.67%, for an annualized return of 9.4% (not including any dividends or dividend reinvestments).

How much is Utah Medical Products's stock price per share?

(NASDAQ: UTMD) Utah Medical Products stock price per share is $67.84 today (as of Jun 12, 2026).

What is Utah Medical Products's Market Cap?

(NASDAQ: UTMD) Utah Medical Products's market cap is $216.00M, as of Jun 13, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Utah Medical Products's market cap is calculated by multiplying UTMD's current stock price of $67.84 by UTMD's total outstanding shares of 3,184,025.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.